Kairos Pharma Ltd.
KAPA | AMEX
$1.71
-$0.08 (-4.47%)
Sep 22, 2026, 11:33 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Net Income | -5.45M | -2.6M | -1.81M | -1.05M | -2.15M | -1.05M |
Depreciation & Amortization | 160K | 160K | 160K | 160K | 98K | n/a |
Stock-Based Compensation | n/a | 218K | 913K | n/a | 300K | 800K |
Other Working Capital | -806K | -1.98M | 764K | 129K | 1.19M | 212.82K |
Other Non-Cash Items | 2.65M | 254K | 56K | 408K | 144K | n/a |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -806K | -1.98M | 764K | 129K | 1.19M | 212.82K |
Operating Cash Flow | -3.44M | -3.96M | 81K | -353K | -412K | -38.54K |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | 5 |
Cash Acquisitions | n/a | n/a | n/a | n/a | -109K | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | -109K | n/a |
Debt Repayment | n/a | n/a | n/a | 895K | 330K | 50K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 3.6M | -390K | n/a | -121K | n/a | -13K |
Financial Cash Flow | 6.66M | 5.13M | -425K | 717K | 580K | 37K |
Net Cash Flow | 3.22M | 1.18M | -344K | 364K | 59K | -1.54K |
Free Cash Flow | -3.44M | -3.96M | 81K | -353K | -412K | -38.54K |
Adj. Free Cash Flow | -3.44M | -4.17M | -832K | -353K | -712K | -838.54K |
Maintenance CapEx | n/a | n/a | n/a | n/a | n/a | n/a |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | 5 |
Owner Earnings | -3.44M | -3.96M | 81K | -353K | -412K | -38.54K |
Add to Watchlist
Select watchlists to add or remove KAPA